Percutaneous Peritoneovenous Shunt for Treatment of Refractory Ascites

Jong Yun Won, Sun Young Choi, Heung kyu Ko, Seung Hyung Kim, Kwang Hun Lee, Jong Tae Lee, Do Yun Lee

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Purpose: To evaluate the usefulness of a percutaneously placed peritoneovenous shunt (PVS) in patients with refractory ascites. Materials and Methods: Under fluoroscopic and ultrasonographic (US) guidance, the authors placed a PVS in 55 patients (39 men and 16 women; mean age, 56 years) with refractory ascites and symptomatic abdominal distention. The cause of ascites was liver cirrhosis (n = 36), carcinomatosis (n = 17), ruptured cysts with polycystic kidney disease (n = 1), and idiopathic refractory ascites (n = 1). The authors retrospectively evaluated technical feasibility, shunt patency, complications, and clinical outcomes of each patient. Results: The technical success rate was 100%, and symptomatic improvement was achieved in all but one patient. Complications occurred in 17 of the 55 patients (31%): five patients had variceal bleeding; three patients had ascites leakage; two patients each had disseminated intravascular coagulopathy, transient abdominal pain, shunt infection, and venous thrombosis; and one patient had pulmonary thromboembolism. Thirty patients (54%) died 2-690 days after the procedure (mean, 117 days), and their lifetime shunt patency was 84%. Eight patients were lost to follow-up. Seventeen patients were alive for 60-1,200 days, and their shunt patency was 71%. There was no significant difference in shunt patency between the two groups with benign and malignant ascites. Conclusions: The percutaneous placement of a PVS was a technically feasible and effective method for symptomatic relief of refractory ascites.

Original languageEnglish
Pages (from-to)1717-1722
Number of pages6
JournalJournal of Vascular and Interventional Radiology
Issue number12
StatePublished - Dec 2008


Dive into the research topics of 'Percutaneous Peritoneovenous Shunt for Treatment of Refractory Ascites'. Together they form a unique fingerprint.

Cite this